• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov3
Shrader's Focus on Healthcare Industry Stocks
17:02
Oct30
Inmune Bio released FY2025 9 Months earnings on October 30 After-Market EST, actual revenue USD 50K, actual EPS USD -1.7261
23:00
Inmune Bio released FY2025 Q3 earnings on October 30 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2434 (forecast USD -0.325)
23:00
Oct23
Inmune Bio to Release FY2025 Q3 Earnings on October 30 After-Market EST, Forecast EPS USD -0.325
00:05
Aug7
Inmune Bio released FY2025 Semi-Annual earnings on August 7 After-Market EST, with actual revenue of USD 50K and EPS of USD -1.4933
23:00
Inmune Bio released FY2025 Q2 earnings on August 7 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.0497 (forecast USD -0.3816)
23:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.472 M, EPS -0.2434

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -24.46 M, EPS -1.0497

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 50 K, Net Income -9.739 M, EPS -0.4329

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More